Amyloidosis therapy research led by the Amyloidosis and Cancer Theranostics Program has resulted in a published article in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).
This peer-reviewed journal carries an impact factor of 10. Impact factor is the frequency with which the average article in a journal is cited in a particular year, and only approximately 2% of journals carry an impact factor of 10+.
This speaks highly of the caliber of research being conducted at the UT Graduate School of Medicine and the significance it may have upon the health care community. Congratulations to Director Jonathan Wall, PhD, and his team.
Wall JS, Williams AD, Foster JS, Richey T, Stuckey A, Macy S, Wooliver C, Campagna SR, Tague ED, Farmer AT, Lands RH, Martin EB, Heidel RE, Kennel SJ.
Bifunctional amyloid-reactive peptide promotes binding of antibody 11-1F4 to diverse amyloid types and enhances therapeutic efficacy. Proceedings of the National Academy of Sciences of the United States of America. 2018 Oct 30. [Epub ahead of print]
Posted November 21, 2018
The University of Tennessee Graduate School of Medicine
1924 Alcoa Highway
Knoxville, Tennessee 37920 | 865-305-9290
Copyright © 2019